Antithrombotic Treatment After Left Atrial Appendage Occlusion in Older Atrial Fibrillation Patients
Year: 2025
Type: article
Study design: Observational Study
Abstract: Left atrial appendage occlusion (LAAO) is an alternative to oral anticoagulants (OAC) for stroke prevention in nonvalvular atrial fibrillation (NVAF); however, real-world data on adherence to its postprocedural treatment protocol remain limited. We evaluated post-LAAO antithrombotic treatment patterns in a cohort of 16304 NVAF patients (mean [SD] age = 78 [6]; 47% female; CHA2DS2-VASc score = 5.0 [1.5]) undergoing first-time LAAO using Optum claims data 2015-2024. OAC discontinuation was defined as a ≥ 60-day gap in supply, and prolonged OAC use was operationally defined as either (1) an OAC refill following a TEE performed 30–90 days post-implantation or (2) OAC refill beyond 90 days post-implantation, regardless of TEE completion. Among LAAO recipients, 9844 (60%) received concomitant OAC and 3499 (10%) received P2Y12 inhibitor at implantation. Transesophageal echocardiography (TEE) was performed in 11237 (69%) patients at 45 (±15) days. Among OAC users (n = 9844), 30% and 85% discontinued OAC by 45 days and 6 months post-implantation, respectively; only 23% patients followed the standard postprocedural protocol. Common deviation from the protocol included no TEE at 45 (±15) days (30%), early OAC discontinued (22%), continued OAC use post-TEE (10%), and P2Y12 inhibitor initiated early or not initiated (10%). Prolonged OAC use was observed in 1970 patients. Factors associated with a higher likelihood of prolonged OAC use included older age, Black race, cardio ablation, and a longer duration of prior OAC use. These findings suggest moderate to low adherence to the LAAO postprocedural protocol, warranting further evaluation of the clinical impact of these adherence patterns.
Source: Innovation in Aging
Institutions: Brigham and Women's Hospital, Massachusetts General Hospital
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,977
OpenAlex ID: W7118080068
FWCI:
Cites:
Cited by:
Related to: